ReACT Study
Phase 2
145
about 11 years
22+
2 sites in MA
What this study is about
This trial is testing if a personalized treatment plan can be created for people with HPV-related oropharyngeal cancers. The treatment plan uses information about the cancer stage and a blood test to check for HPV DNA. Participants will receive chemotherapy, radiation therapy, and/or NavDx® HPV ctDNA testing.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Radiotherapy
- 2.Take Chemotherapy drug
- 3.Use NavDx HPV ctDNA Testing
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Progression Free Survival 2 Years
Secondary: Best Overall Response, Overall Survival at 2 Years, Safety and Toxicity
radiation
Oncology